US company develops breakthrough 200,000 lux LED technology

This breakthrough provides light intensity that is comparable to most 300-watt fibre optic xenon headlight systems that are commonly used by “deep cavity” surgeons, such as cardio, colo-rectal, neuro, orthopedic, thoracic, and vascular surgeons.

The company introduced its technology during The American College of Surgeons (ACS) 93rd Clinical Congress, held last week – October 7-11, 2007 – at the Morial Convention Centre in New Orleans, Louisiana.

The company used its new lighting technology in the IRIS™ 2X Cordless Surgical Headlight, a new product being designed specifically for deep cavity surgeons. The anticipated commercial release date will be in the first quarter of 2008.

“We have aggressively invested in research and development to find a way to double the light output of our cordless surgical headlights. Our goal from the very beginning has been to meet the lighting needs of all surgical disciplines, particularly those with the greatest illumination needs, and to further free them from the constraints and burdens of standard fibre optic systems. Now, we've done it!” said Fariborz Boor Boor, the company's CEO. “It is a thrill to be on the cutting edge of surgical lighting technology and to see the IRIS 2X come together. We look forward to making it available to surgeons in the very near future.”

Enova Medical Technologies, a privately held company, is engaged in the discovery, development and commercialization of proprietary medical devices and is an experienced provider of product development, manufacturing, and commercialization services for the medical device industry. From Class I to Class III devices, Enova understands the technical challenges of product design, engineering, research and development, the regulatory steps required to successfully commercialise products, and the marketing and sales efforts needed to move inventory off the shelf. For more information, visit http://www.enovamedical.com.